| Dr Khan Asif Shabih, MD | |
|
2345 Chesterfield Ave, Suite 301, Charleston, WV 25304-1062 | |
| (304) 344-2900 | |
| (304) 344-9385 |
| Full Name | Dr Khan Asif Shabih |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 35 Years |
| Location | 2345 Chesterfield Ave, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285720524 | NPI | - | NPPES |
| 1809497000 | Medicaid | WV | |
| 550722686 | Other | WV | PRACTICE TAX ID# |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 21267 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Ripley | Ripley, WV | Dialysis facility |
| Fmc Hawks Nest | Montgomery, WV | Dialysis facility |
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than the current standard treatment, according to researchers who conducted a multi-center, randomized controlled trial. The results will be presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.
As many as 30% of people with drug-resistant tuberculosis can be successfully treated with first-line drugs, Paul van Helden of the University of Stellenbosch's Center of Excellence for Biomedical TB Research said recently while presenting research on drug-resistant TB at a TB symposium in Maputo, Mozambique, Africa Science News Service reports.
› Verified 9 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than the current standard treatment, according to researchers who conducted a multi-center, randomized controlled trial. The results will be presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.
As many as 30% of people with drug-resistant tuberculosis can be successfully treated with first-line drugs, Paul van Helden of the University of Stellenbosch's Center of Excellence for Biomedical TB Research said recently while presenting research on drug-resistant TB at a TB symposium in Maputo, Mozambique, Africa Science News Service reports.
› Verified 9 days ago
| Entity Name | Kanawha Nephrology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770682395 PECOS PAC ID: 1557370947 Enrollment ID: O20060412000575 |
News Archive
A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than the current standard treatment, according to researchers who conducted a multi-center, randomized controlled trial. The results will be presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.
As many as 30% of people with drug-resistant tuberculosis can be successfully treated with first-line drugs, Paul van Helden of the University of Stellenbosch's Center of Excellence for Biomedical TB Research said recently while presenting research on drug-resistant TB at a TB symposium in Maputo, Mozambique, Africa Science News Service reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Khan Asif Shabih, MD 2345 Chesterfield Ave, Suite 301, Charleston, WV 25304-1062 Ph: (304) 344-2900 | Dr Khan Asif Shabih, MD 2345 Chesterfield Ave, Suite 301, Charleston, WV 25304-1062 Ph: (304) 344-2900 |
News Archive
A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than the current standard treatment, according to researchers who conducted a multi-center, randomized controlled trial. The results will be presented at the American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a new combination of drugs.
To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.
As many as 30% of people with drug-resistant tuberculosis can be successfully treated with first-line drugs, Paul van Helden of the University of Stellenbosch's Center of Excellence for Biomedical TB Research said recently while presenting research on drug-resistant TB at a TB symposium in Maputo, Mozambique, Africa Science News Service reports.
› Verified 9 days ago
Dr. Asif Rahman, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2345 Chesterfield Ave, Suite 301, Charleston, WV 25304 Phone: 304-344-2900 Fax: 304-344-9385 | |
David L Namay, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3411 B Noyes Avenue Se, Charleston, WV 25304 Phone: 304-720-3206 Fax: 304-720-3207 | |
Joseph Jarrell, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 333 Laidley St Ste 605, Charleston, WV 25301 Phone: 304-720-7235 Fax: 304-720-7236 | |
Samar Ryiad Sankari, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1097 Fledderjohn Rd, Charleston, WV 25314 Phone: 304-720-1963 Fax: 304-720-1966 | |
Brittain Mcjunkin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-347-1300 | |
Rupali N. Sangrampurkar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3200 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-5848 Fax: 304-388-9654 | |
George Zaldivar, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3100 Maccorkle Avenue Se, Suite 404, Charleston, WV 25304 Phone: 304-346-1811 Fax: 304-343-3086 |